Biocon Q3 Results: Firm posts Rs 42 cr loss on one-time exceptional item
The profit was also impacted due to dilution of Biocon’s stake in Biocon Biologics and Syngene. Net profit for the quarter, excluding an exceptional item, stood at Rs 140 crore
